NAPOLI, 2008 - Google Patents
Corticosteroids Confer Highest Infection RiskNAPOLI, 2008
View PDF- Document ID
- 15611454026785387309
- Author
- NAPOLI D
- Publication year
- Publication venue
- Rheumatology News
External Links
Snippet
Corticosteroids Confer Highest Infection Risk Page 1 ©2008 Ferring Pharmaceuticals Inc. 2/08
EUF-87196B BRIEF SUMMARY Please consult package insert for full Prescribing Information.
INDICATION EUFLEXXA™ (1% sodium hyaluronate) is indicated for the treatment of pain in …
- 201000009910 diseases by infectious agent 0 title description 13
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Manchikanti et al. | Transforaminal epidural injections in chronic lumbar disc herniation: a randomized, double-blind, active-control trial | |
| Kane | Review of treatments that can ameliorate nonadherence in patients with schizophrenia | |
| Manchikanti et al. | Comparative outcomes of a 2-year follow-up of cervical medial branch blocks in management of chronic neck pain: A randomized, double-blind controlled trial | |
| JP7025039B2 (en) | Composition of hyaluronan with high elasticity and its use | |
| Ballow | Optimizing immunoglobulin treatment for patients with primary immunodeficiency disease to prevent pneumonia and infection incidence: review of the current data | |
| CN103260636A (en) | Therapeutic agent for disc herniation | |
| Jain et al. | Botox in dentistry: The healing side of A poison | |
| EP3838246A1 (en) | Drug management method for kit formulation requiring dose adjustment | |
| NAPOLI | Corticosteroids Confer Highest Infection Risk | |
| Jones et al. | Investigation of depot neuroleptic injection site reactions | |
| Saoji et al. | A comparative study of disability and pain assessment by Shoulder Pain and Disability Index (SPADI) Score in patients of adhesive capsulitis treated by hydrodilatation with and without corticosteroids | |
| Chiran et al. | Intravenous laser blood irradiation and tocilizumab in a patient with juvenile arthritis | |
| Chayasirisobhon et al. | Occurrence of neuroleptic malignant syndrome in a narcoleptic patient | |
| JP7033848B2 (en) | Intradermal administration of immunoglobulin G preparation | |
| AULT | MedPAC Flags Rising Hospice Costs, Longer Stays | |
| Pincus et al. | Possible discontinuation of therapies in inflammatory rheumatic diseases–as with initiation of therapies, a shared decision between patient and rheumatologist | |
| Schwab et al. | Recent experiences with parenteral dilantin | |
| Brunner et al. | Healthcare Provider Administration of Biologics for Patients with Plaque Psoriasis: Literature Review and Clinical Considerations | |
| WALSH | Smoking Lessens Response to TNF Blockers | |
| JANCIN | Aortic Surgery in Marfan Predisposes to Migraine | |
| Park et al. | Herpes zoster as a sequelae of various kinds of COVID-19 vaccination: a case series | |
| S Mohamed et al. | Ultrasound-Guided Lumbar Erector Spinae Plane Block compared to Quadratus Lumborum Block for Postoperative Analgesia in Inguinal Hernia repair operations | |
| SCHNEIDER | New Pulmonary Fibrosis Treatments in Pipeline | |
| El Mershati et al. | 1ISG-022 Hospital pharmacists’ perceptions of their profession in two European countries | |
| Arpa | Does acetaminophen in comparison to ibuprofen effectively reduce fevers in children younger than 18 years of age? |